{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:38:34Z","timestamp":1790401114854,"version":"4.1.0"},"reference-count":68,"publisher":"Impact Journals, LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2025,4,4]]},"DOI":"10.18632\/oncotarget.28710","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T17:21:29Z","timestamp":1743787289000},"page":"262-272","source":"Crossref","is-referenced-by-count":2,"title":["Association between two single nucleotide polymorphisms of the Prostaglandin-Endoperoxide Synthase 1 and 2 genes and cell proliferative prostatic diseases in Lebanon"],"prefix":"10.18632","volume":"16","author":[{"given":"Brock J.","family":"Sheehan","sequence":"first","affiliation":[{"name":"Department of Biology, Utah Valley University, Orem, UT 84058, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryson","family":"Edwards","sequence":"additional","affiliation":[{"name":"Department of Biology, Utah Valley University, Orem, UT 84058, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivanna Soto","family":"Medrano","sequence":"additional","affiliation":[{"name":"Department of Biology, Utah Valley University, Orem, UT 84058, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed A.","family":"El-Saidi","sequence":"additional","affiliation":[{"name":"Department of Strategic Management and Operations, Utah Valley University, Orem, UT 84058, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wissam R.","family":"Zaidan","sequence":"additional","affiliation":[{"name":"Radioimmunoassay Laboratory, Lebanese Atomic Energy Commission, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmahan A.","family":"El-Ezzi","sequence":"additional","affiliation":[{"name":"Radioimmunoassay Laboratory, Lebanese Atomic Energy Commission, Beirut, Lebanon"},{"name":"Department of Chemistry and Biochemistry, Lebanese University, Hadath, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruhul H.","family":"Kuddus","sequence":"additional","affiliation":[{"name":"Department of Biology, Utah Valley University, Orem, UT 84058, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2025,4,4]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/gb-2004-5-9-241","article-title":"The cyclooxygenases","volume":"5","author":"Simmons","year":"2004","journal-title":"Genome Biol"},{"key":"2","unstructured":"GeneCards. The Human Gene Database. 2024. https:\/\/www.genecards.org\/."},{"key":"3","unstructured":"NIH Gene Table. 2024. https:\/\/www.ncbi.nlm.nih.gov\/gene\/5742."},{"key":"4","doi-asserted-by":"publisher","first-page":"13313","DOI":"10.1073\/pnas.95.22.13313","article-title":"Pharmacological analysis of cyclooxygenase-1 in inflammation","volume":"9","author":"Isakson","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1111\/j.1582-4934.2008.00430.x","article-title":"Cyclooxygenase in normal human tissues--is COX-1 really a constitutive isoform, and COX-2 an inducible isoform?","volume":"1","author":"Stajer","year":"2009","journal-title":"J Cell Mol Med"},{"key":"6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/s0090-6980(02)00028-x","article-title":"Phenotypes of the COX-deficient mice indicate physiological and pathophysiological roles for COX-1 and COX-2","volume":"68","author":"Langenbach","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"7","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/jnci\/90.6.455","article-title":"Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer","volume":"9","author":"Levine","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"8","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.1158\/0008-5472.CAN-04-3814","article-title":"Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer","volume":"6","author":"Dey","year":"2005","journal-title":"Cancer Res"},{"key":"9","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3892\/or.2018.6785","article-title":"Downregulation of cyclooxygenase-1 stimulates mitochondrial apoptosis through the NF-\u03baB signaling pathway in colorectal cancer cells","volume":"4","author":"Cui","year":"2019","journal-title":"Oncol Rep"},{"key":"10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/ph11040101","article-title":"Cyclooxygenase-1 (COX-1) and COX-1 Inhibitors in Cancer: A Review of Oncology and Medicinal Chemistry Literature","volume":"1","author":"Coluccia","year":"2018","journal-title":"Pharmaceuticals (Basel)"},{"key":"11","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1001\/jama.282.13.1254","article-title":"The relationship between cyclooxygenase-2 expression and colorectal cancer","volume":"28","author":"Murray","year":"1999","journal-title":"JAMA"},{"key":"12","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/S1470-2045(07)70280-2","article-title":"COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial","volume":"8","author":"Dicker","year":"2007","journal-title":"Lancet Oncol"},{"key":"13","doi-asserted-by":"publisher","first-page":"2048731","DOI":"10.1155\/2016\/2048731","article-title":"Cyclooxygenase-2: A Role in Cancer Stem Cell Survival and Repopulation of Cancer Cells during Therapy","volume":"201","author":"Argyle","year":"2016","journal-title":"Stem Cells Int"},{"key":"14","unstructured":"SNPedia. 2024. https:\/\/www.snpedia.com\/index.php\/SNPedia."},{"key":"15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.cytogfr.2009.05.005","article-title":"Implications of cytokine gene polymorphisms on the orchestration of the immune response: lessons learned from oral diseases","volume":"2","author":"Gomez","year":"2009","journal-title":"Cytokine Growth Factor Rev"},{"key":"16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-60327-411-1_1","article-title":"SNPs: impact on gene function and phenotype","volume":"57","author":"Shastry","year":"2009","journal-title":"Methods Mol Biol"},{"key":"17","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1007\/s10552-013-0282-1","article-title":"COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations","volume":"2","author":"Caan","year":"2013","journal-title":"Cancer Causes Control"},{"key":"18","doi-asserted-by":"publisher","first-page":"e71126","DOI":"10.1371\/journal.pone.0071126","article-title":"A meta-analysis of PTGS1 and PTGS2 polymorphisms and NSAID intake on the risk of developing cancer","volume":"8","author":"Yamauchi","year":"2013","journal-title":"PLoS One"},{"key":"19","doi-asserted-by":"publisher","first-page":"214","DOI":"10.4103\/0970-1591.126909","article-title":"BPH and prostate cancer risk","volume":"3","author":"Catto","year":"2014","journal-title":"Indian J Urol"},{"key":"20","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"7","author":"Jemal","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"21","doi-asserted-by":"publisher","first-page":"811044","DOI":"10.3389\/fpubh.2022.811044","article-title":"Prostate Cancer Incidence and Mortality: Global Status and Temporal Trends in 89 Countries From 2000 to 2019","volume":"1","author":"Du","year":"2022","journal-title":"Front Public Health"},{"key":"22","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1097\/01.ju.0000155709.37840.fe","article-title":"Urologic diseases in America project: benign prostatic hyperplasia","volume":"17","author":"Jacobsen","year":"2005","journal-title":"J Urol"},{"key":"23","doi-asserted-by":"publisher","first-page":"e754","DOI":"10.1016\/S2666-7568(22)00213-6","article-title":"The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"3","author":"GBD 2019 Benign Prostatic Hyperplasia Collaborators","year":"2022","journal-title":"Lancet Healthy Longev"},{"key":"24","unstructured":"Center for Disease Control and Prevention. Prostate Cancer Incidence by Stage at Diagnosis. 2024. https:\/\/www.cdc.gov\/united-states-cancer-statistics\/publications\/prostate-cancer.html."},{"key":"25","unstructured":"Worldometer. Lebanon population. 2024. https:\/\/www.worldometers.info\/world-population\/lebanon-population\/#:~:text=87.8%20%25%20of%20the%20population%20is,in%20Lebanon%20is%2028.6%20years."},{"key":"26","unstructured":"The World Factbook (CIA). Lebanon. 2024. https:\/\/www.cia.gov\/the-world-factbook\/countries\/lebanon\/."},{"key":"27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1055\/s-0040-1721291","article-title":"Cancer in Lebanon: A Review of Incidence Rates from 2008 to 2015 and Projections Till 2025","volume":"9","author":"Fouad","year":"2020","journal-title":"South Asian J Cancer"},{"key":"28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/2090598X.2021.2010451","article-title":"Prevalence of benign prostatic hyperplasia among the adult general population of five Middle Eastern Countries: Results of the SNAPSHOT programme","volume":"2","author":"El Hasnaoui","year":"2022","journal-title":"Arab J Urol"},{"key":"29","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1111\/1755-0998.12654","article-title":"Minimum sample sizes for population genomics: an empirical study from an Amazonian plant species","volume":"1","author":"Lohmann","year":"2017","journal-title":"Mol Ecol Resour"},{"key":"30","doi-asserted-by":"publisher","first-page":"e45170","DOI":"10.1371\/journal.pone.0045170","article-title":"Sampling for microsatellite-based population genetic studies: 25 to 30 individuals per population is enough to accurately estimate allele frequencies","volume":"7","author":"Steeves","year":"2012","journal-title":"PLoS One"},{"key":"31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/sj.hdy.6800548","article-title":"Do polymorphic loci require large sample sizes to estimate genetic distances?","volume":"9","author":"Kalinowski","year":"2005","journal-title":"Heredity (Edinb)"},{"key":"32","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00384-009-0656-8","article-title":"Genetic polymorphisms in the cyclooxygenase-1 and cyclooxygenase-2 genes and risk of colorectal adenoma","volume":"2","author":"Hebert","year":"2009","journal-title":"Int J Colorectal Dis"},{"key":"33","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s10528-016-9722-4","article-title":"Cyclooxygenase 2 (rs2745557) Polymorphism and the Susceptibility to Benign Prostate Hyperplasia and Prostate Cancer in Egyptians","volume":"5","author":"Saadawy","year":"2016","journal-title":"Biochem Genet"},{"key":"34","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1111\/j.1464-410X.2011.10161.x","article-title":"Associations between variants in the cyclooxygenase 2 enzyme gene (PTGS2) and development of benign prostate enlargement","volume":"10","author":"Jacobsen","year":"2011","journal-title":"BJU Int"},{"key":"35","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1111\/ijcp.12220","article-title":"Adding Cyclooxygenase-2 inhibitor to alpha blocker for patients with benign prostate hyperplasia and elevated serum prostate specific antigen could not improve prostate biopsy detection rate but improve lower urinary tract symptoms","volume":"6","author":"Kuo","year":"2013","journal-title":"Int J Clin Pract"},{"key":"36","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.urols.2011.07.001","article-title":"Effect of celecoxib on benign prostatic hyperplasia: Results of a preliminary study","volume":"2","author":"Shirinkar","year":"2011","journal-title":"Urol Sci"},{"key":"37","doi-asserted-by":"publisher","first-page":"15579883231176667","DOI":"10.1177\/15579883231176667","article-title":"The Efficacy of Cyclooxygenase-2 Inhibitors for the Male Treatment of Lower Urinary Tract Symptoms: A Systematic Review and Meta-Analysis","volume":"1","author":"Wu","year":"2023","journal-title":"Am J Mens Health"},{"key":"38","first-page":"5401","article-title":"Associations of cyclooxygenase 2 polymorphic genotypes with bladder cancer risk in Taiwan","volume":"3","author":"Bau","year":"2013","journal-title":"Anticancer Res"},{"key":"39","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.arcmed.2011.10.005","article-title":"Polymorphisms in COX-2 gene influence prostate cancer susceptibility in a northern Indian cohort","volume":"4","author":"Mittal","year":"2011","journal-title":"Arch Med Res"},{"key":"40","first-page":"221","article-title":"Association of cyclooxygenase 2 polymorphic genotypes with prostate cancer in taiwan","volume":"3","author":"Bau","year":"2011","journal-title":"Anticancer Res"},{"key":"41","doi-asserted-by":"publisher","first-page":"13391","DOI":"10.4238\/2015.October.28.1","article-title":"Lack of association between the cyclooxygenase 2 -765G>C polymorphism and prostate cancer risk: a meta-analysis","volume":"1","author":"Li","year":"2015","journal-title":"Genet Mol Res"},{"key":"42","first-page":"1961","article-title":"[Association between single nucleotide polymorphisms in the promoter of cyclooxygenase COX-2 gene and hereditary susceptibility to pancreatic cancer]","volume":"8","author":"Lin","year":"2008","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"43","doi-asserted-by":"publisher","first-page":"5510","DOI":"10.3748\/wjg.v16.i43.5510","article-title":"Cyclooxygenase-2 polymorphisms and susceptibility to gastric carcinoma: a meta-analysis","volume":"1","author":"Xing","year":"2010","journal-title":"World J Gastroenterol"},{"key":"44","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.3748\/wjg.14.1498","article-title":"Polymorphism of -765G > C COX-2 is a risk factor for gastric adenocarcinoma and peptic ulcer disease in addition to H pylori infection: a study from northern India","volume":"1","author":"Husain","year":"2008","journal-title":"World J Gastroenterol"},{"key":"45","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1590\/0102-6720201700020008","article-title":"Polymorphism of the COX-2 gene and susceptibility to colon and rectal cancer","volume":"3","author":"Poli-Frederico","year":"2017","journal-title":"Arq Bras Cir Dig"},{"key":"46","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.1007\/s11033-011-1319-8","article-title":"PTGS2 (COX2) -765G>C gene polymorphism and risk of sporadic colorectal cancer in Iranian population","volume":"3","author":"Mohamadhashem","year":"2012","journal-title":"Mol Biol Rep"},{"key":"47","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.4103\/0973-1482.172110","article-title":"Cyclooxygenase-2 gene polymorphisms and susceptibility to hepatocellular carcinoma: A meta-analysis based on 10 case-control studies","volume":"1","author":"Li","year":"2018","journal-title":"J Cancer Res Ther"},{"key":"48","doi-asserted-by":"publisher","first-page":"e94790","DOI":"10.1371\/journal.pone.0094790","article-title":"Meta-analysis of the association between COX-2 polymorphisms and risk of colorectal cancer based on case-control studies","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"49","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11033-009-9685-1","article-title":"-765G>C and 8473T>C polymorphisms of COX-2 and cancer risk: a meta-analysis based on 33 case-control studies","volume":"3","author":"Liu","year":"2010","journal-title":"Mol Biol Rep"},{"key":"50","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1590\/s0004-28032014000200002","article-title":"-765 g>c polymorphism of the cox-2 gene and gastric cancer risk in Brazilian population","volume":"5","author":"Forones","year":"2014","journal-title":"Arq Gastroenterol"},{"key":"51","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1007\/s12032-010-9627-8","article-title":"Cyclooxygenase-2 gene and lung carcinoma risk","volume":"2","author":"Agachan","year":"2011","journal-title":"Med Oncol"},{"key":"52","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12253-014-9792-8","article-title":"Cyclooxygenase-2 polymorphisms and breast cancer associated risk in Pakistani patients","volume":"2","author":"Pervez","year":"2015","journal-title":"Pathol Oncol Res"},{"key":"53","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.gene.2018.10.077","article-title":"Roles of Cyclooxygenase-2 gene -765G > C (rs20417) and -1195G > A (rs689466) polymorphisms in gastric cancer: A systematic review and meta-analysis","volume":"68","author":"Chen","year":"2019","journal-title":"Gene"},{"key":"54","doi-asserted-by":"publisher","first-page":"e105254","DOI":"10.1371\/journal.pone.0105254","article-title":"Intestinal PTGS2 mRNA levels, PTGS2 gene polymorphisms, and colorectal carcinogenesis","volume":"9","author":"Andersen","year":"2014","journal-title":"PLoS One"},{"key":"55","first-page":"490","article-title":"Race, ethnicity and benign prostatic hyperplasia in the health professionals follow-up study","volume":"16","author":"Giovannucci","year":"2000","journal-title":"J Urol"},{"key":"56","doi-asserted-by":"publisher","first-page":"110635","DOI":"10.18632\/oncotarget.22372","article-title":"Single nucleotide polymorphisms and cancer susceptibility","volume":"8","author":"Yuan","year":"2017","journal-title":"Oncotarget"},{"key":"57","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/j.1464-410X.2008.07667.x","article-title":"Genetic polymorphism and pathogenesis of benign prostatic hyperplasia","volume":"10","author":"Bid","year":"2008","journal-title":"BJU Int"},{"key":"58","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ajhg.2019.07.003","article-title":"Extreme Polygenicity of Complex Traits Is Explained by Negative Selection","volume":"10","author":"Price","year":"2019","journal-title":"Am J Hum Genet"},{"key":"59","article-title":"The Database of Short Genetic Variation (dbSNP)","author":"Holmes","year":"2024","journal-title":"The NCBI Handbook 2nd Edition"},{"key":"60","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1530\/eje.0.1470479","article-title":"Impact of constitutional genetic variation in androgen\/oestrogen-regulating genes on age-related changes in human prostate","volume":"14","author":"Cussenot","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"61","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s43586-021-00056-9","article-title":"Genome-wide association studies","volume":"1","author":"Posthuma","year":"2021","journal-title":"Nat Rev Methods Primers"},{"key":"62","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1158\/2159-8290.CD-15-1227","article-title":"Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types","volume":"6","author":"Michael","year":"2016","journal-title":"Cancer Discov"},{"key":"63","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41576-019-0127-1","article-title":"Benefits and limitations of genome-wide association studies.","volume":"2","author":"Meyre","year":"2019","journal-title":"Nat Rev Genet"},{"key":"64","first-page":"13","article-title":"Is there a link between BPH and prostate cancer?","volume":"25","author":"Challacombe","year":"2012","journal-title":"Practitioner"},{"key":"65","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrurol.2012.192","article-title":"The link between benign prostatic hyperplasia and prostate cancer","volume":"1","author":"Bojesen","year":"2013","journal-title":"Nat Rev Urol"},{"key":"66","doi-asserted-by":"publisher","first-page":"436123","DOI":"10.1155\/2014\/436123","article-title":"Nonsteroidal anti-inflammatory drugs and prostatic diseases","volume":"201","author":"Kawahara","year":"2014","journal-title":"Biomed Res Int"},{"key":"67","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.tcmj.2011.03.001","article-title":"A cyclooxygenase-2 inhibitor reduces serum prostatic-specific antigen levels in men with benign prostatic hyperplasia and lower urinary tract symptoms and helps differentiate chronic inflammation from prostate cancer","volume":"2","author":"Kuo","year":"2011","journal-title":"Tzu Chi Med J"},{"key":"68","unstructured":"World Medical Association. WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. 2024. https:\/\/www.wma.net\/policies-post\/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects\/."}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.28710","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T17:21:43Z","timestamp":1743787303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.28710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,4]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,4,4]]}},"alternative-id":["28710"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.28710","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,4]]}}}